Journal profile · ONCOLOGY
JCO Precision Oncology
ISSN 2473-4284 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · continuous publishing · Founded 2017
JCO Precision Oncology: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 4.64; hybrid open access; median 128 days to acceptance (108 articles, last 24 months); 313 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
JCO Precision Oncology is published by Lippincott Williams and Wilkins Ltd. and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations and Genetic factors in colorectal cancer, together about 33.8% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)
Impact and Reach: With over 18 million article views and 10 million unique visitors, the JCO Journals ensure that practice-changing research gets in the hands of people who need it most. JCO Journals received over 190,000 citations in 2022. EZSubmit: JCO Journals have adopted a format-free submission policy (EZSubmit). New submissions are not scrutinized for compliance with our formatting guidelines (reference style, word limits, order of components, etc). As long as the required information is present (cover letter, title page, references, CONSORT diagram for randomized studies, protocol for randomized and interventional trials, etc), the manuscript will be considered by the editors. Exceptionally Quick Review Process: While striving for the quickest turnaround possible, JCO Journals also offer Rapid Review and Fast Track review for select papers. Innovative Content: JCO Journals not only showcase practice-changing research and guidelines but also provide context for readers. Expert Editorials, Understanding the Pathways, Clinical Reviews, and Guidelines Q&A are just some examples of content that translate the latest research discoveries in practice.
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology16.7%
- Lung Cancer Treatments and MutationsMedicine10.1%
- Genetic factors in colorectal cancerMedicine7.1%
- BRCA gene mutations in cancerBiochemistry, Genetics and Molecular Biology5.4%
- Cancer Immunotherapy and BiomarkersMedicine5%
- Lung Cancer Research StudiesMedicine4.5%
- Colorectal Cancer Treatments and StudiesMedicine4.1%
- PARP inhibition in cancer therapyMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.64LetPub ·
- CiteScore 2026-06
- 6.2LetPub ·
- SJR 2026-06
- 2.08LetPub ·
- SNIP 2026-06
- 1.05LetPub ·
- h-index
- 77OpenAlex ·
- i10-index
- 820OpenAlex ·
- 2-year mean citedness
- 3.37OpenAlex ·
- Self-citation rate
- 6.4%LetPub ·
- Share of gold OA articles
- 38.04%LetPub ·
Volume
- Articles per year
- 245LetPub ·
Articles by year OpenAlex count · 2,108 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 238 | 133 | 82 |
| 2025 | 313 | 195 | 778 |
| 2024 | 286 | 180 | 1,957 |
| 2023 | 235 | 159 | 2,614 |
| 2022 | 224 | 166 | 4,125 |
| 2021 | 205 | 164 | 4,448 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
128 daysMedian, submission to acceptance · P25–P75 92 days – 171 days
- Acceptance to online
- median 42 days (108 articles)
- Submission to online
- median 171 days
- Sample
- 108 articles with submission and acceptance dates (635 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 4 weeksLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- First submission
- Free format: the journal's layout is not required
- Cover letter
- Required
Policy excerpts from the journal's websitePeer review
- Peer review
Rapid Review and Fast Track review offered for select papers. Model summary
While striving for the quickest turnaround possible, JCO Journals also offer Rapid Review and Fast Track review for select papers.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- continuous publishing
- Founded
- 2017
- ISSN
- 2473-4284
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about JCO Precision Oncology
What CAS zone is JCO Precision Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, JCO Precision Oncology is in Zone 2 of Medicine, and in Zone 2 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JCO Precision Oncology?
The latest impact factor listed by LetPub is 4.64; CiteScore 6.2, h-index 77.
How long does peer review take at JCO Precision Oncology?
Based on the dates recorded on 108 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 128 days (interquartile range 92–171 days); authors report an average review time of about 4 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of JCO Precision Oncology?
According to the journal's author guidelines: First submission: Free format: the journal's layout is not required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index JCO Precision Oncology?
According to LetPub and DOAJ records, JCO Precision Oncology is indexed in SCIE and Scopus.
Is JCO Precision Oncology open access, and what is the APC?
JCO Precision Oncology is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .